BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 23187075)

  • 1. [Space flight/bedrest immobilization and bone. Osteocyte as a sensor of mechanical stress and Wnt signal].
    Sakai A
    Clin Calcium; 2012 Dec; 22(12):1829-35. PubMed ID: 23187075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanical stress and Wnt signal].
    Sakai A
    Clin Calcium; 2013 Jun; 23(6):839-45. PubMed ID: 23719496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Space flight/bedrest immobilization and bone. Signaling cascade induced by mechanical stress].
    Kido R; Matsumoto T
    Clin Calcium; 2012 Dec; 22(12):1837-43. PubMed ID: 23187076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
    Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L
    J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocytes and WNT: the mechanical control of bone formation.
    Galli C; Passeri G; Macaluso GM
    J Dent Res; 2010 Apr; 89(4):331-43. PubMed ID: 20200416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
    Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
    J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
    Sapir-Koren R; Livshits G
    Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocyte-Mediated Translation of Mechanical Stimuli to Cellular Signaling and Its Role in Bone and Non-bone-Related Clinical Complications.
    Yan Y; Wang L; Ge L; Pathak JL
    Curr Osteoporos Rep; 2020 Feb; 18(1):67-80. PubMed ID: 31953640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system.
    Niedźwiedzki T; Filipowska J
    J Mol Endocrinol; 2015 Oct; 55(2):R23-36. PubMed ID: 26307562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Wnt/β-catenin signaling within and from osteocytes.
    Burgers TA; Williams BO
    Bone; 2013 Jun; 54(2):244-9. PubMed ID: 23470835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
    Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
    J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.
    Poole KE; van Bezooijen RL; Loveridge N; Hamersma H; Papapoulos SE; Löwik CW; Reeve J
    FASEB J; 2005 Nov; 19(13):1842-4. PubMed ID: 16123173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of bone mass regulation by mechanical stress].
    Komori T
    Clin Calcium; 2013 Nov; 23(11):1559-67. PubMed ID: 24162595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human primary osteocyte differentiation in a 3D culture system.
    Boukhechba F; Balaguer T; Michiels JF; Ackermann K; Quincey D; Bouler JM; Pyerin W; Carle GF; Rochet N
    J Bone Miner Res; 2009 Nov; 24(11):1927-35. PubMed ID: 19419324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocyte deficiency in hip fractures.
    Delgado-Calle J; Arozamena J; García-Renedo R; García-Ibarbia C; Pascual-Carra MA; González-Macías J; Riancho JA
    Calcif Tissue Int; 2011 Oct; 89(4):327-34. PubMed ID: 21874545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does osteocytic SOST suppression mediate PTH bone anabolism?
    Kramer I; Keller H; Leupin O; Kneissel M
    Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.
    Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM
    J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro.
    Hens JR; Wilson KM; Dann P; Chen X; Horowitz MC; Wysolmerski JJ
    J Bone Miner Res; 2005 Jul; 20(7):1103-13. PubMed ID: 15940363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone Cell Biology Assessed by Microscopic Approach. Response to mechanical stress by osteocyte network].
    Komori T
    Clin Calcium; 2015 Oct; 25(10):1467-74. PubMed ID: 26412725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.